Main Session
Sep
29
SS 42 - Advanced Lung Cancer and Drug Combinations
274 - Osimertinib Combined with Stereotactic Body Radiotherapy vs. Osimertinib Alone in Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase II Randomized Controlled Trial
Presenter(s)
Xiaoli Zheng, MD - The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Beijing, Beijing